Skip to main content
Erschienen in: Journal of Cancer Research and Clinical Oncology 17/2023

05.09.2023 | Research

Precise pattern of lymphatic spread of esophageal squamous cell carcinoma: results of 1074 patients with N1 disease

verfasst von: Kailin Lin, Bin Li, Yihua Sun, Hong Hu, Yawei Zhang, Jiaqing Xiang, Haiquan Chen

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 17/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The route of lymphatic spread in esophageal cancer remains unclear. The present study aimed to determine the pattern of lymphatic metastasis in its early stages.

Methods

The data were reviewed of 1074 patients who underwent curative esophagectomy for thoracic esophageal squamous cell carcinoma and metastasis in 1–2 lymph nodes between January 2015 and December 2021. The frequencies of lymph node metastasis were analyzed by the anatomic sites and regions involved.

Results

Of the 1074 patients, 668 patients (62.2%) with one positive lymph node and 406 (37.8%) with two positive lymph nodes. Paracardial lymph nodes were the most frequently involved nodes (35.1%), followed by right thoracic recurrent nerve nodes (24.0%), middle thoracic paraesophageal nodes (14.7%), left thoracic recurrent nerve nodes (10.4%), subcarinal nodes (8.0%), lower thoracic paraesophageal nodes (7.8%), and upper thoracic paraesophageal nodes (5.7%). The frequency of lymph node metastasis in other sites was less than 3%. The majority of lymph node metastases occurred in the longitudinal direction to the perigastric (36.5%) and bilateral recurrent nerve regions (33.4%) and in the transverse direction to the paraesophageal region (27.7%). As the tumor location changed from the upper to the lower thoracic esophagus, the frequencies of lymph node metastasis decreased in the bilateral recurrent nerve region but increased in the perigastric region.

Conclusion

Bilateral recurrent nerve nodes, paraesophageal lymph nodes, and perigastric nodes were the most common sites of early lymph node metastasis. Esophageal squamous cell carcinoma involves more longitudinal than transverse lymph node metastases.
Literatur
Zurück zum Zitat Altorki N (2022) Two-field lymph node dissection or three-field lymph node dissection. What’s in a name? J Thorac Cardiovasc Surg 163:1695–1697CrossRefPubMed Altorki N (2022) Two-field lymph node dissection or three-field lymph node dissection. What’s in a name? J Thorac Cardiovasc Surg 163:1695–1697CrossRefPubMed
Zurück zum Zitat Chen J, Cai W, Lin Y, Chen Y, Zheng Q, Pan J, Chen C (2017) Patterns and rates of abdominal lymphatic metastasis following esophageal carcinoma. PLoS ONE 12:e0185424CrossRefPubMedPubMedCentral Chen J, Cai W, Lin Y, Chen Y, Zheng Q, Pan J, Chen C (2017) Patterns and rates of abdominal lymphatic metastasis following esophageal carcinoma. PLoS ONE 12:e0185424CrossRefPubMedPubMedCentral
Zurück zum Zitat Dresner SM, Wayman J, Shenfine J, Harris A, Hayes N, Griffin SM (2000) Pattern of recurrence following subtotal oesophagectomy with two field lymphadenectomy. Br J Surg 87:362–373PubMed Dresner SM, Wayman J, Shenfine J, Harris A, Hayes N, Griffin SM (2000) Pattern of recurrence following subtotal oesophagectomy with two field lymphadenectomy. Br J Surg 87:362–373PubMed
Zurück zum Zitat Hagens ERC, van Berge Henegouwen MI, van Sandick JW, Cuesta MA, van der Peet DL, Heisterkamp J, Nieuwenhuijzen GAP, Rosman C, Scheepers JJG, Sosef MN, van Hillegersberg R, Lagarde SM, Nilsson M, Räsänen J, Nafteux P, Pattyn P, Hölscher AH, Schröder W, Schneider PM, Mariette C, Castoro C, Bonavina L, Rosati R, de Manzoni G, Mattioli S, Garcia JR, Pera M, Griffin M, Wilkerson P, Chaudry MA, Sgromo B, Tucker O, Cheong E, Moorthy K, Walsh TN, Reynolds J, Tachimori Y, Inoue H, Matsubara H, Kosugi SI, Chen H, Law SYK, Pramesh CS, Puntambekar SP, Murthy S, Linden P, Hofstetter WL, Kuppusamy MK, Shen KR, Darling GE, Sabino FD, Grimminger PP, Meijer SL, Bergman J, Hulshof M, van Laarhoven HWM, Mearadji B, Bennink RJ, Annema JT, Dijkgraaf MGW, Gisbertz SS (2019) Distribution of lymph node metastases in esophageal carcinoma [TIGER study]: study protocol of a multinational observational study. BMC Cancer 19:662CrossRefPubMedPubMedCentral Hagens ERC, van Berge Henegouwen MI, van Sandick JW, Cuesta MA, van der Peet DL, Heisterkamp J, Nieuwenhuijzen GAP, Rosman C, Scheepers JJG, Sosef MN, van Hillegersberg R, Lagarde SM, Nilsson M, Räsänen J, Nafteux P, Pattyn P, Hölscher AH, Schröder W, Schneider PM, Mariette C, Castoro C, Bonavina L, Rosati R, de Manzoni G, Mattioli S, Garcia JR, Pera M, Griffin M, Wilkerson P, Chaudry MA, Sgromo B, Tucker O, Cheong E, Moorthy K, Walsh TN, Reynolds J, Tachimori Y, Inoue H, Matsubara H, Kosugi SI, Chen H, Law SYK, Pramesh CS, Puntambekar SP, Murthy S, Linden P, Hofstetter WL, Kuppusamy MK, Shen KR, Darling GE, Sabino FD, Grimminger PP, Meijer SL, Bergman J, Hulshof M, van Laarhoven HWM, Mearadji B, Bennink RJ, Annema JT, Dijkgraaf MGW, Gisbertz SS (2019) Distribution of lymph node metastases in esophageal carcinoma [TIGER study]: study protocol of a multinational observational study. BMC Cancer 19:662CrossRefPubMedPubMedCentral
Zurück zum Zitat Kuge K, Murakami G, Mizobuchi S, Hata Y, Aikou T, Sasaguri S (2003) Submucosal territory of the direct lymphatic drainage system to the thoracic duct in the human esophagus. J Thorac Cardiovasc Surg 125:1343–1349CrossRefPubMed Kuge K, Murakami G, Mizobuchi S, Hata Y, Aikou T, Sasaguri S (2003) Submucosal territory of the direct lymphatic drainage system to the thoracic duct in the human esophagus. J Thorac Cardiovasc Surg 125:1343–1349CrossRefPubMed
Zurück zum Zitat Li B, Chen H, Xiang J, Zhang Y, Li C, Hu H, Zhang Y (2012) Pattern of lymphatic spread in thoracic esophageal squamous cell carcinoma: a single-institution experience. J Thorac Cardiovasc Surg 144:778–785 (discussion 785–6)CrossRefPubMed Li B, Chen H, Xiang J, Zhang Y, Li C, Hu H, Zhang Y (2012) Pattern of lymphatic spread in thoracic esophageal squamous cell carcinoma: a single-institution experience. J Thorac Cardiovasc Surg 144:778–785 (discussion 785–6)CrossRefPubMed
Zurück zum Zitat Li B, Hu H, Zhang Y, Zhang J, Miao L, Ma L, Luo X, Zhang Y, Ye T, Li H, Zhou J, Li Y, Shen L, Zhao K, Fan M, Zhu Z, Wang J, Xu J, Deng Y, Lu Q, Jia H, Cheng X, Li H, Zhang Y, Li C, Pan Y, Liu S, Hu H, Shao L, Sun Y, Xiang J, Chen H (2018) Extended right thoracic approach compared with limited left thoracic approach for patients with middle and lower esophageal squamous cell carcinoma: three-year survival of a prospective, randomized, open-label trial. Ann Surg 267:826–832CrossRefPubMed Li B, Hu H, Zhang Y, Zhang J, Miao L, Ma L, Luo X, Zhang Y, Ye T, Li H, Zhou J, Li Y, Shen L, Zhao K, Fan M, Zhu Z, Wang J, Xu J, Deng Y, Lu Q, Jia H, Cheng X, Li H, Zhang Y, Li C, Pan Y, Liu S, Hu H, Shao L, Sun Y, Xiang J, Chen H (2018) Extended right thoracic approach compared with limited left thoracic approach for patients with middle and lower esophageal squamous cell carcinoma: three-year survival of a prospective, randomized, open-label trial. Ann Surg 267:826–832CrossRefPubMed
Zurück zum Zitat Li B, Zhang Y, Miao L, Ma L, Luo X, Zhang Y, Ye T, Li H, Zhang J, Li Y, Zhao K, Fan M, Zhu Z, Wang J, Xu J, Deng Y, Lu Q, Li H, Zhang Y, Pan Y, Liu S, Shao L, Sun Y, Xiang J, Hu H, Chen H (2021) Esophagectomy with three-field versus two-field lymphadenectomy for middle and lower thoracic esophageal cancer: long-term outcomes of a randomized clinical trial. J Thorac Oncol 16:310–317CrossRefPubMed Li B, Zhang Y, Miao L, Ma L, Luo X, Zhang Y, Ye T, Li H, Zhang J, Li Y, Zhao K, Fan M, Zhu Z, Wang J, Xu J, Deng Y, Lu Q, Li H, Zhang Y, Pan Y, Liu S, Shao L, Sun Y, Xiang J, Hu H, Chen H (2021) Esophagectomy with three-field versus two-field lymphadenectomy for middle and lower thoracic esophageal cancer: long-term outcomes of a randomized clinical trial. J Thorac Oncol 16:310–317CrossRefPubMed
Zurück zum Zitat Miyata H, Sugimura K, Motoori M, Omori T, Yamamoto K, Yanagimoto Y, Shinno N, Yasui M, Takahashi H, Wada H, Ohue M, Yano M (2019) Clinical features of metastasis from superficial squamous cell carcinoma of the thoracic esophagus. Surgery 166:1033–1040CrossRefPubMed Miyata H, Sugimura K, Motoori M, Omori T, Yamamoto K, Yanagimoto Y, Shinno N, Yasui M, Takahashi H, Wada H, Ohue M, Yano M (2019) Clinical features of metastasis from superficial squamous cell carcinoma of the thoracic esophagus. Surgery 166:1033–1040CrossRefPubMed
Zurück zum Zitat Mizutani M, Murakami G, Nawata S, Hitrai I, Kimura W (2006) Anatomy of right recurrent nerve node: why does early metastasis of esophageal cancer occur in it? Surg Radiol Anat 28:333–338CrossRefPubMed Mizutani M, Murakami G, Nawata S, Hitrai I, Kimura W (2006) Anatomy of right recurrent nerve node: why does early metastasis of esophageal cancer occur in it? Surg Radiol Anat 28:333–338CrossRefPubMed
Zurück zum Zitat Rice TW, Ishwaran H, Ferguson MK, Blackstone EH, Goldstraw P (2017) Cancer of the esophagus and esophagogastric junction: an eighth edition staging primer. J Thorac Oncol 12:36–42CrossRefPubMed Rice TW, Ishwaran H, Ferguson MK, Blackstone EH, Goldstraw P (2017) Cancer of the esophagus and esophagogastric junction: an eighth edition staging primer. J Thorac Oncol 12:36–42CrossRefPubMed
Zurück zum Zitat Samson P, Puri V, Broderick S, Patterson GA, Meyers B, Crabtree T (2017) Extent of lymphadenectomy is associated with improved overall survival after esophagectomy with or without induction therapy. Ann Thorac Surg 103:406–415CrossRefPubMed Samson P, Puri V, Broderick S, Patterson GA, Meyers B, Crabtree T (2017) Extent of lymphadenectomy is associated with improved overall survival after esophagectomy with or without induction therapy. Ann Thorac Surg 103:406–415CrossRefPubMed
Zurück zum Zitat Staubitz JI, van der Sluis PC, Berlth F, Watzka F, Dette F, Läßig A, Lang H, Musholt TJ, Grimminger PP (2020) Recurrent laryngeal nerve monitoring during totally robot-assisted Ivor Lewis esophagectomy. Langenbecks Arch Surg 405:1091–1099CrossRefPubMedPubMedCentral Staubitz JI, van der Sluis PC, Berlth F, Watzka F, Dette F, Läßig A, Lang H, Musholt TJ, Grimminger PP (2020) Recurrent laryngeal nerve monitoring during totally robot-assisted Ivor Lewis esophagectomy. Langenbecks Arch Surg 405:1091–1099CrossRefPubMedPubMedCentral
Metadaten
Titel
Precise pattern of lymphatic spread of esophageal squamous cell carcinoma: results of 1074 patients with N1 disease
verfasst von
Kailin Lin
Bin Li
Yihua Sun
Hong Hu
Yawei Zhang
Jiaqing Xiang
Haiquan Chen
Publikationsdatum
05.09.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Cancer Research and Clinical Oncology / Ausgabe 17/2023
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-023-05359-w

Weitere Artikel der Ausgabe 17/2023

Journal of Cancer Research and Clinical Oncology 17/2023 Zur Ausgabe

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.